The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
HealthDay on MSN2d
Multiple Sclerosis May Worsen With Menopause TransitionThe menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Researchers at the University of Colorado Anschutz Medical Campus have identified LL-341070, a promising drug candidate that ...
The study identified gene expression changes which were detected beginning three months after intranasal dosing of foralumab in our ongoing ISPPEA (or expanded access program). Key findings include ...
FOX 9 Minneapolis-St. Paul on MSN2d
Edina, Minnetonka high school basketball rivals team up to ‘beat’ MSThe Minnetonka and Edina Girls Basketball teams are rivals on the court, but now they are joining forces to defeat a common ...
The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback